Search Results 281-290 of 11345 for Antifungal Resistance

1. Duvelisib And Nivolumab For The Treatment Of Stage IIB-IVB Mycosis Fungoides And Sezary Syndrome - Mayo Clinic

   Uncontrolled infection requiring systemic antimicrobials: Patients on antibacterial, antifungal, and antiviral prophylaxis will not be excluded if all other ...

2. A Study To Assess The Safety And Tolerability Of CFT8634 In Locally Advanced Or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma And SMARCB1-Null Tumors - Mayo Clinic

   Concurrent administration of strong cytochrome P450 (CYP) 3A4 inhibitors and inducers, and multidrug resistance mutation 1 inhibitors. Note: If a subject ...

3. Clinical trials - Oncology (Medical)

   ... resistant chronic lymphocytic leukemia. Patients will be randomized 1:1 into the two arms. Patients randomized to GDC-0199+R will be given GDC-0199 daily ...

4. Medical Research & Education - Mayo Clinic News Network

   Study finds lung transplant patients not given antifungal preventive drugs have higher risk of death featured. Minnesota. Study finds lung transplant patients ...

5. Hematology - Clinical trials

   This study is being performed to understand the causes of drug resistance and to improve the treatment options for patients diagnosed with B-cell cancers. We ...

6. Infectious Diseases - Mayo Clinic News Network

   Understanding and preventing antimicrobial resistance featured image. Understanding and preventing antimicrobial resistance. Vincent Jacobbi. November 17, 2025.

7. Rituximab-pvvr (intravenous route) - Mayo Clinic

   You may receive non live vaccines at least 4 weeks before starting treatment with this medicine. Rituximab-pvvr may lower your body's resistance, and there is a ...

8. A Study to Evaluate Treatment of Established Chemotherapy-induced Neuropathy with Fingolimod - Mayo Clinic

   ... fungal infections, skin cancer, or diabetes. Myocardial infarction, unstable angina, stroke, TIA, decompensated heart failure requiring hospitalization or ...

9. Medical Research & Education - Mayo Clinic News Network

   Study finds lung transplant patients not given antifungal preventive drugs have higher risk of death featured. Minnesota. Study finds lung transplant patients ...

10. A Study of Fecal Microbiota Transplantation for Recurrent Clostridium Difficile Infection on Vancomycin Resistant Enterococci Status of Patients - Mayo Clinic

    The purpose of this study is to evaluate if Vancomycin Resistant Enterococci (VRE) can be eradicated in patients with Clostridium Difficile infection (CDI) ...